EUROMACS
The European Registry for Patients with Mechanical Circulatory Support (EUROMACS) offers the tools to collect clinical procedural updates and scientific data for patients in advanced stages of heart failure who have undergone durable mechanical circulatory support (MCS) procedures.
In the ever-evolving field of MCS, EUROMACS is a valuable resource for monitoring outcomes, tracking device performance, benchmarking outcomes with collaborators worldwide and refining patient care.
Since the registry was founded in 2009, EUROMACS data has continued to serve as a catalyst for scientific studies, fostering continuous research and innovation in the field of MCS.
